CUBIST PHARMACEUTICALS INC Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31)
CUBIST PHARMACEUTICALS INC reported Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) of $5.20 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense · last filed 2012-08-07
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $5.20M, a 766.67% increase year-over-year.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $5.20M, a 766.67% increase year-over-year.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $1.60M, a 128.57% increase year-over-year.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $600.00K, a 14.29% decline year-over-year.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2011 was $3.50M, a 20.69% increase from fiscal 2010.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2010 was $2.90M, a 0.00% change from fiscal 2009.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2009 was $2.90M.
| Period end | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 3 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 6 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 9 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-06-30 | $5.20M 10-Q · filed 2012-08-07 | $10.40M 10-Q · filed 2012-08-07 | $12.00M derived: sum of 3 quarters · filed 2012-08-07 | $12.60M derived: sum of 4 quarters · filed 2012-08-07 |
| 2012-03-31 | $5.20M 10-Q · filed 2012-05-01 | $6.80M derived: sum of 2 quarters · filed 2012-05-01 | $7.40M derived: sum of 3 quarters · filed 2012-05-01 | $8.00M derived: sum of 4 quarters · filed 2012-08-07 |
| 2011-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $2.20M derived: sum of 2 quarters · filed 2012-02-27 | $2.80M derived: sum of 3 quarters · filed 2012-08-07 | $3.50M 10-K · filed 2012-02-27 |
| 2011-09-30 | $600.00K 10-Q · filed 2011-11-02 | $1.20M derived: sum of 2 quarters · filed 2012-08-07 | $1.90M 10-Q · filed 2011-11-02 | $2.50M derived: sum of 4 quarters · filed 2012-08-07 |
| 2011-06-30 | $600.00K 10-Q · filed 2012-08-07 | $1.30M 10-Q · filed 2012-08-07 | $1.90M derived: sum of 3 quarters · filed 2012-08-07 | $2.60M derived: sum of 4 quarters · filed 2012-08-07 |
| 2011-03-31 | $600.00K 10-Q · filed 2012-05-01 | $1.30M derived: sum of 2 quarters · filed 2012-05-01 | $2.00M derived: sum of 3 quarters · filed 2012-05-01 | $2.70M derived: sum of 4 quarters · filed 2012-05-01 |
| 2010-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $1.40M derived: sum of 2 quarters · filed 2012-02-27 | $2.10M derived: sum of 3 quarters · filed 2012-02-27 | $2.90M 10-K · filed 2012-02-27 |
| 2010-09-30 | $700.00K 10-Q · filed 2011-11-02 | $1.40M derived: sum of 2 quarters · filed 2011-11-02 | $2.20M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $700.00K 10-Q · filed 2011-07-29 | $1.50M 10-Q · filed 2011-07-29 | ||
| 2009-12-31 | $2.90M 10-K · filed 2012-02-27 |